Professional Documents
Culture Documents
Nano-Sorbent Materials For Pharmaceutical-Based Wastewater Effluents - An Overview
Nano-Sorbent Materials For Pharmaceutical-Based Wastewater Effluents - An Overview
PII: S2666-0164(20)30026-8
DOI: https://doi.org/10.1016/j.cscee.2020.100028
Reference: CSCEE 100028
Please cite this article as: K.M. Aguilar-Pérez, J.I. Avilés-Castrillo, G. Ruiz-Pulido, Nano-sorbent
materials for pharmaceutical-based wastewater effluents - An overview, Case Studies in Chemical and
Environmental Engineering, https://doi.org/10.1016/j.cscee.2020.100028.
This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition
of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of
record. This version will undergo additional copyediting, typesetting and review before it is published
in its final form, but we are providing this version to give early visibility of the article. Please note that,
during the production process, errors may be discovered which could affect the content, and all legal
disclaimers that apply to the journal pertain.
Abstract
Wastewater treatment has been one of the biggest challenges to overcome
worldwide, being pharmaceutical effluents some of the main residues associated
with water pollution. The implementation of nanotechnology to remove
pharmaceutical pollutants from respective wastewater effluents, such as
antibiotics, pesticides, hormones, antiviral drugs, toxic dyes, among others, has
been increasing during the last decades. The sorbent materials produced at
nanoscale offer unique properties, such as high absorption, large surface area,
eco-friendly fabrication, and huge affinity to organic and inorganic compounds. This
article aims to provide an overview for researchers about some of the current
nanotechnology applications for the treatment of pharmaceutical-based wastewater
effluents. Sustainable exploitation of novel nano-sorbent materials could be useful
for environmental purposes focused on the removal of pollutants in water.
Keywords: Wastewater; Emerging contaminants; Nanomaterials; Environmental
impact
Catalytic
chemical vapor
Hydroxylated
deposition XPS, FT-IR,
multi-walled
technique Acetaminophen BET, SEM, ~74% [17]
carbon nanotubes
TEM, TGA
(H-MWCNT)
Oxidation with
H2SO4
Chemical vapor
Ozone treated
deposition
multi-walled SEM, FT-IR,
technique Acetaminophen ~ 95 % [44]
carbon nanotubes XRD
(MWCNT)
Ozonation
Acetaminophen ~100%
Naproxen ~70%
Multi-walled Chemical vapor
Ibuprofen ~70%
carbon nanotubes deposition TEM, TGA [45]
Ketoprofen ~40%
(MWCNT) technique
Nadolol ~70%
Bisoprolol ~40%
Catalytic
Carboxylate
chemical vapor
group
deposition
functionalized Ethidium SEM, FT-IR,
technique ~ 38.42% [48]
single-walled bromide TGA
carbon nanotubes
Oxidation with
(SWCNT)
H2SO4
Magnetic
multi-walled Co-precipitation XRD, TGA,
Naproxen ~67.2% [49]
carbon nanotubes method SEM, FT-IR
(M-MWCNT)
Chemical vapor
deposition ~53.1 -
Multi-walled
technique SEM, FT-IR, 99.9%
carbon nanotubes Tetracycline [52]
EDS, XRD, pH
(MWCNT)
Oxidation with variations
H2SO4:H2O2
Table 2 Biogenic nanomaterials for wastewater treatment of pharmaceutical
compounds.
Nanomaterial Synthesis Contaminant Characterization Percentage Reference
process techniques removal
Keratine NPs Fuji and Kato Crystal violet FTIR, UV-vis, 75.97% [32]
from human method XRD, SEM, TEM,
hair AFM
Pt and Pd NPs Extracellular Ibuprofen, 17b- TEM, HPLC, UV- 94, 85 and [53]
with microbial estradiol, vis. 70%
Desulfovibrio synthesis sulfamethoxazole
vulgaris andcipro- floxacin
Fe3O4/Au Chemical Imatinib and XRD, FTIR, UV- 92% and [59]
nanocomposite reduction imipenem vis, SEM, DRS, 96%
with Carum VSM
carvi L. seeds
Table 3 Nanofiltration membranes for pharmaceutical wastewater treatment; N/A
not Available.
Nanomaterial Synthesis Contaminant Mean Characterization Percentage Reference
process pore techniques removal
size
(nm)
Dually charged Layer by Atenolol, N/A FTIR, SEM, AFM, 81.67%, [39]
polyelectrolyte layer carbamazepine contact angle and 92.5% and
multilayer technique , and ibuprofen zeta potential 89.85%
membrane of
polyethersulfo
ne,
polydopamine
and
quaternate
chitosan
Polyethersulfo Non-solvent Direct red 16 3.53- FTIR, AFM,SEM, 99.21% and [30]
ne membrane induced and Methylene 5.01 contact angle, 98.53%
with para phase blue zeta potential and
hydroxybenzo inversion UV-VIS
ate alumoxane method spectroscopy
filler
Polyacrylonitril Immersion Direct red 16 3.83 FTIR, SEM, AFM, 92% and [44]
e with Fe- precipitation and Methylene contact angle, x- 95%
based phase blue ray diffraction,
nanoparticles inversion inductively
coupled plasma
atomic emission
spectrometer and
atomic absorption
spectroscopy
Polyamide and Interfacial Na2SO4, 0.5- FE-SEM, EDX, From 94.36% [48]
polyethersulfo polymerizati MgSO4, MgCl2 0.7 XPS, AFM, to 98.35%
ne membrane on and NaCl contact angle,
with Beta conductivity and
zeolite zeta potential
Polyether Phase Na2SO4 and 3.4 FTIR, X-ray 80% and [46]
imide inversion CrSO4 diffraction, SEM, 79%
membrane method AFM, contact
with L-cysteine angle
functionalized
glycidyl-
polyhedral
oligomeric
silsesquioxane
nanoparticles
Fully aromatic N/A Carbamazepine 0.34 Contact angle, Higher than [47]
polyamide , ibuprofen, SEM, laser 90%
TFC NF90 sulfadiazine, particle size
with Humic sulfamethoxazo analyzer and
acid, alginate le, HPLC
and silica sulfamethazine
and triclosan
List of abbreviations
Abbreviations